Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  612 results for ""Cytochrome P-450 CYP3A""

Your Filters

Subject : drugs and therapies
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Periodical

"Methods for the Prevention and Treatment of Hearing Loss" in Patent Application Approval Process (USPTO 20240350492).

Subjects: THERAPEUTICS; NEUROLOGICAL disorders; CYTOCHROME P-450 CYP3A

  • Source: Drug Week; 11/15/2024, p3639-3639, 1p

Record details

Read More Add to Saved list
×
Periodical

Researcher at Department of Medical Oncology Releases New Data on Non-Small Cell Lung Cancer (Optimizing Treatment Strategies for Egfr-Mutated Non-Small-Cell Lung Cancer Treated with Osimertinib: Real-World Outcomes and Insights).

Subjects: CYTOCHROME P-450 CYP3A; NON-small-cell lung carcinoma; PROTEIN-tyrosine kinase inhibitors

  • Source: Drug Week; 11/15/2024, p1048-1048, 1p

Record details

Read More Add to Saved list
×
Periodical

Researchers from South China University of Technology Provide Details of New Studies and Findings in the Area of Cancer (Supramolecular Self-assembly Strategy for the Enhanced Solubility/ Dissolution Rate and Anti-cancer Efficacy of...).

Subjects: CYTOCHROME P-450 CYP3A; ANTINEOPLASTIC agents; TECHNOLOGICAL innovationsGUANGZHOU (China)

  • Source: Drug Week; 11/15/2024, p1151-1151, 1p

Record details

Read More Add to Saved list
×
Periodical

Certara UK Ltd. Researchers Discuss Findings in Pharmaceutics (Applications of the Cholesterol Metabolite, 4b-Hydroxycholesterol, as a Sensitive Endogenous Biomarker for Hepatic CYP3A Activity Evaluated within a PBPK Framework).

Subjects: CYTOCHROME P-450 CYP3A; PHARMACEUTICAL services; NEWSPAPER editors

  • Source: Drug Week; 11/15/2024, p460-460, 1p

Record details

Read More Add to Saved list
×
Periodical

New Findings from Beijing Normal University in Kinase Inhibitors Provides New Insights (Synthesis and Bioevaluation of a Novel 99mtc-labeled Complex With a Crizotinib Hynic Derivative for Imaging of C-met-positive Expression).

Subjects: CYTOCHROME P-450 CYP3A; NUCLEAR chemistry; ANALYTICAL radiochemistry

  • Source: Medical Imaging Week; 11/9/2024, p1656-1656, 1p

Record details

Read More Add to Saved list
×
Periodical

National and Kapodistrian University of Athens Researchers Add New Data to Research in Kinase Inhibitors (Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatment).

Subjects: INTERMEDIATE filament proteins; CYTOCHROME P-450 CYP3A; PROTEIN kinase inhibitors

  • Source: Drug Week; 11/8/2024, p1485-1485, 1p

Record details

Read More Add to Saved list
×
Periodical

Studies from Manipal College of Pharmaceutical Sciences Further Understanding of Kinase Inhibitors (Should the Use of Acid Reducing Agents In Conjunction With Ribociclib Be Avoided? an Integrated Qbd Approach for Assessment of Ph-mediated...).

Subjects: CYTOCHROME P-450 CYP3A; PHARMACEUTICAL chemistry; REPORTERS & reporting

  • Source: Drug Week; 11/8/2024, p3168-3168, 1p

Record details

Read More Add to Saved list
×
Periodical

Researchers' from Princess Nourah bint Abdulrahman University Report Details of New Studies and Findings in the Area of Personalized Medicine (Development of novel CDK9 and CYP3A4 inhibitors for cancer therapy through field and computational...).

Subjects: CYTOCHROME P-450 CYP3A; PROTEIN-ligand interactions; MOLECULAR dynamics

  • Source: Drug Week; 11/8/2024, p1287-1287, 1p

Record details

Read More Add to Saved list
×
Periodical

University of Santo Tomas Researcher Furthers Understanding of Hepatitis (Histologic Patterns of Ribociclib-induced Liver Injury).

Subjects: DIGESTIVE system diseases; CYTOCHROME P-450 CYP3A; LIVER enzymes

  • Source: Hepatitis Weekly; 11/4/2024, p1894-1894, 1p

Record details

Read More Add to Saved list
×
Periodical

Research on Breast Cancer Detailed by Researchers at Financial Research Institute (Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A...).

Subjects: CELL cycle proteins; SERINE/THREONINE kinases; HEMOPROTEINS

  • Source: Women's Health Weekly; 11/5/2024, p1128-1128, 1p

Record details

Read More Add to Saved list
×
  • 1-10 of  612 results for ""Cytochrome P-450 CYP3A""